Nicotinamide adenine dinucleotide — NAD+ — is a coenzyme present in every cell of the body, at an average total level of roughly 3 grams, and it sits at the center of an enormous range of physiological processes.1 It's the molecule mitochondria depend on to generate ATP, the cell's basic energy currency; it's essential to DNA repair enzymes; and it fuels sirtuins, a family of proteins involved in cellular stress response. Understanding NAD+'s biology is the foundation for understanding why mitochondrial health — and the broader NAD+-precursor category of supplementation — has become such an active area of research.
Why NAD+ matters at the cellular level
NAD+ has a “key relevance in supporting mitochondrial function,” in the words of a 2025 comprehensive review published in npj Metabolic Health and Disease — and mitochondrial function, in turn, underpins nearly everything a cell does that requires energy.2 Mitochondria don't just produce ATP passively; they're dynamic organelles with their own quality-control systems, including mitophagy (the process of clearing damaged mitochondria) and an unfolded protein response that manages cellular stress. NAD+ availability directly influences how well these systems function.2
Why NAD+ levels decline with age
This is well-documented, reproducible biology, not a speculative claim: declining NAD+ levels are consistently associated with aging and with several chronic conditions, including cognitive decline, sarcopenia (age-related muscle loss), and metabolic disease.2 Several distinct mechanisms contribute to this decline. One well-characterized pathway involves the immune system: as cells accumulate age-related changes, certain immune cells increase expression of NAD+-consuming enzymes (CD38 and poly-ADP-ribose polymerases, or PARPs), which actively depletes available NAD+.3 Separately, aging is associated with declining mitochondrial function in immune cells, which increases secretion of inflammatory signaling molecules — creating a feedback loop where inflammation and NAD+ depletion reinforce each other.3
Recent work has also clarified how NAD+ is distributed and buffered within the cell: a 2024 study published in Nature Metabolism found that NAD+ pools across different cellular compartments are interconnected and specifically buffered by mitochondrial NAD+ — meaning mitochondria act as a kind of reservoir that helps stabilize NAD+ availability elsewhere in the cell.4 This kind of foundational mechanistic work is what allows researchers to more precisely understand where and how interventions aimed at NAD+ might actually act.
Why this has become an active area of longevity research
Because NAD+ decline is mechanistically connected to multiple hallmarks of aging — not just one isolated pathway — restoring or maintaining NAD+ levels has become a widely studied strategy, whether through vitamin B3-family precursor compounds or other approaches.12 A 2026 integrated framework published in Redox Biology specifically examines how NAD+ homeostasis, mitochondrial quality control, and redox stability interact as a coordinated system, rather than as separate, independent targets — reflecting how the field has moved toward understanding aging biology holistically rather than chasing single molecules in isolation.2
This is also why formulating for mitochondrial and NAD+ support benefits from a multi-compound approach rather than a single ingredient: NAD+ precursors address one input into the system (raising the coenzyme's availability), while ingredients supporting mitochondrial quality control, antioxidant defense, and cellular stress response address other, complementary parts of the same biological network.
What the evidence actually supports today
It's worth being precise about what's well-established versus what remains an active research question. The biology of NAD+ decline with age, its mechanistic links to mitochondrial dysfunction, and its centrality to cellular energy metabolism are all well-documented in the peer-reviewed literature. What individual NAD+ precursor compounds accomplish in human clinical trials varies by compound and by outcome measured — some raise blood NAD+ levels reliably (see our look at the NR evidence specifically), while translating that increase into a specific measurable health outcome is a separate, ongoing area of research for the field as a whole.
The practical takeaway
NAD+ isn't a trendy molecule — it's one of the most fundamental coenzymes in human metabolism, and its age-related decline is a genuinely well-characterized phenomenon with clear mechanistic links to mitochondrial health, inflammation, and multiple hallmarks of aging. That's the solid biological foundation underneath the broader interest in NAD+-supportive formulation — the honest next question, compound by compound, is what specific interventions actually accomplish in human trials, which is exactly what's worth examining ingredient by ingredient.